vTv Therapeutics Inc.
VTVT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641489
No open-market purchases or sales by vTv Therapeutics Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $60.5M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in vTv Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −11 vs. Q2 2021
- Shares held
- 3.39M
- −958.6K (−22.1%) vs. Q2 2021
- Total value
- $5.17M
- −$4.72M (−47.7%) vs. Q2 2021
- New holders
- 6
- 7 more added
- Sold out
- 17
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $60.5M |
| Q1 2026 | 35 | $59.0M |
| Q4 2025 | 27 | $51.3M |
| Q3 2025 | 23 | $23.1M |
| Q2 2025 | 21 | $8.74M |
| Q1 2025 | 21 | $9.90M |
| Q4 2024 | 17 | $7.57M |
| Q3 2024 | 20 | $7.34M |
| Q2 2024 | 19 | $6.15M |
| Q1 2024 | 19 | $7.85M |
| Q4 2023 | 14 | $788.7K |
| Q3 2023 | 25 | $1.65M |
| Q2 2023 | 20 | $2.60M |
| Q1 2023 | 24 | $2.88M |
| Q4 2022 | 30 | $2.47M |
| Q3 2022 | 27 | $3.38M |
| Q2 2022 | 23 | $2.75M |
| Q1 2022 | 25 | $3.76M |
| Q4 2021 | 29 | $6.49M |
| Q3 2021 | 31 | $5.17M |
| Q2 2021 | 42 | $9.89M |
| Q1 2021 | 48 | $13.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding vTv Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,760,918 | $2.69M | 0.00% | +2,794+0.2% | Added |
| Geode Capital Management, LLC | 347,635 | $531.0K | 0.00% | +151,435+77.2% | Added |
| Cim Investment Mangement Inc | 177,373 | $271.0K | 0.09% | 00.0% | Unchanged |
| Millennium Management LLC | 146,818 | $225.0K | 0.00% | −147,803−50.2% | Reduced |
| Citadel Advisors LLC | 129,331 | $198.0K | 0.00% | +1,487+1.2% | Added |
| Gsa Capital Partners LLP | 115,472 | $177.0K | 0.02% | +115,472 | New |
| Virtu Financial LLC | 101,678 | $156.0K | 0.01% | +101,678 | New |
| BlackRock Inc. | 98,737 | $150.0K | 0.00% | +847+0.9% | Added |
| Vontobel Holding Ltd. | 80,000 | $123.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 78,895 | $121.0K | 0.00% | +42,139+114.6% | Added |
| State Street Corp | 61,687 | $94.0K | 0.00% | −28,800−31.8% | Reduced |
| Rafferty Asset Management, LLC | 54,530 | $83.0K | 0.00% | +54,530 | New |
| Tower Research Capital LLC (TRC) | 40,857 | $63.0K | 0.00% | +2,036+5.2% | Added |
| Northern Trust Corp | 40,577 | $62.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 24,118 | $37.0K | 0.00% | −8,968−27.1% | Reduced |
| Marshall Wace, LLP | 23,388 | $36.0K | 0.00% | −248,867−91.4% | Reduced |
| Veritable, L.P. | 20,905 | $32.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 17,087 | $26.0K | 0.01% | +17,087 | New |
| Engineers Gate Manager LP | 15,782 | $24.0K | 0.00% | −9,473−37.5% | Reduced |
| ExodusPoint Capital Management, LP | 13,900 | $21.0K | 0.00% | +13,900 | New |
| Game Plan Financial Advisors, LLC | 13,000 | $20.0K | 0.01% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 11,072 | $17.0K | 0.00% | −3,097−21.9% | Reduced |
| Advisor Group Holdings, Inc. | 2,060 | $3.00K | 0.00% | −1,500−42.1% | Reduced |
| Wells Fargo & Company | 2,144 | $3.00K | 0.00% | +19+0.9% | Added |
| Barclays PLC | 1,527 | $2.00K | 0.00% | −1,698−52.7% | Reduced |
| Parallel Advisors, LLC | 1,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 906 | $1.39K | 0.00% | −78−7.9% | Reduced |
| Bank of America Corp | 43 | $0 | 0.00% | −1,674−97.5% | Reduced |
| Royal Bank of Canada | 166 | $0 | 0.00% | −468−73.8% | Reduced |
| Montag A & Associates Inc | 50 | $0 | 0.00% | +50 | New |
| Winthrop Advisory Group LLC | 3,024 | – | – | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −243,250−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −181,613−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −147,695−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −73,289−100.0% | Sold out |
| Citizens Financial Group Inc | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −54,200−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −52,647−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −42,754−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −42,300−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,783−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −26,765−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,045−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −12,444−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −10,610−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3,042−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |